DongKook Pharm total revenue, net income and dynamics of changes in South Korean won today
Net income DongKook Pharm - 15 125 283 260 ₩. Information about net income is used from open sources. The dynamics of DongKook Pharm net income went up. The change was 6 113 717 540 ₩. Here are the main financial indicators of DongKook Pharm. Graph of finance company DongKook Pharm. The financial schedule of DongKook Pharm consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The financial report chart shows the values from 31/12/2018 to 31/03/2021.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
143 895 330 560 ₩
+30.22 % ↑
15 125 283 260 ₩
+21.13 % ↑
31/12/2020
142 069 373 160 ₩
+39.83 % ↑
9 011 565 720 ₩
-35.965 % ↓
30/09/2020
147 630 165 670 ₩
+19.62 % ↑
17 022 994 780 ₩
+12.8 % ↑
30/06/2020
138 796 135 020 ₩
+14.98 % ↑
13 355 478 230 ₩
+9.96 % ↑
30/09/2019
123 413 632 410 ₩
-
15 090 900 490 ₩
-
30/06/2019
120 717 428 130 ₩
-
12 146 061 560 ₩
-
31/03/2019
110 498 011 460 ₩
-
12 487 158 490 ₩
-
31/12/2018
101 600 504 430 ₩
-
14 072 792 550 ₩
-
Show:
to
DongKook Pharm financial report charts
The dates of the latest financial statements of DongKook Pharm: 31/12/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of DongKook Pharm for today is 31/03/2021. Gross profit DongKook Pharm is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit DongKook Pharm is 86 300 981 080 ₩
DongKook Pharm quarterly report dates
Cost of revenue DongKook Pharm is the total cost of producing and distributing of products and services of a company. Cost of revenue DongKook Pharm is 57 594 349 480 ₩ Total revenue DongKook Pharm refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue DongKook Pharm is 143 895 330 560 ₩ Operating income DongKook Pharm is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income DongKook Pharm is 19 605 306 280 ₩
Net income DongKook Pharm is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income DongKook Pharm is 15 125 283 260 ₩ Current assets DongKook Pharm is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets DongKook Pharm is 409 834 321 310 ₩ Total assets DongKook Pharm refers to the total amount of assets owned by a person or entity. Total assets DongKook Pharm is 684 939 985 850 ₩
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
86 300 981 080 ₩
84 020 781 620 ₩
90 084 194 000 ₩
84 009 289 780 ₩
74 427 943 640 ₩
72 872 062 610 ₩
65 738 922 420 ₩
59 358 392 310 ₩
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
57 594 349 480 ₩
58 048 591 540 ₩
57 545 971 670 ₩
54 786 845 240 ₩
48 985 688 770 ₩
47 845 365 520 ₩
44 759 089 040 ₩
42 242 112 120 ₩
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
143 895 330 560 ₩
142 069 373 160 ₩
147 630 165 670 ₩
138 796 135 020 ₩
123 413 632 410 ₩
120 717 428 130 ₩
110 498 011 460 ₩
101 600 504 430 ₩
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
123 413 632 410 ₩
120 717 428 130 ₩
110 498 011 460 ₩
101 600 504 430 ₩
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
19 605 306 280 ₩
19 652 945 170 ₩
25 271 467 310 ₩
18 292 922 730 ₩
18 144 048 370 ₩
15 049 507 990 ₩
14 506 727 940 ₩
12 804 069 180 ₩
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
15 125 283 260 ₩
9 011 565 720 ₩
17 022 994 780 ₩
13 355 478 230 ₩
15 090 900 490 ₩
12 146 061 560 ₩
12 487 158 490 ₩
14 072 792 550 ₩
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
4 765 454 000 ₩
4 151 827 000 ₩
4 997 557 000 ₩
4 962 300 000 ₩
5 413 169 000 ₩
5 523 602 000 ₩
4 192 225 000 ₩
4 278 118 000 ₩
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
124 290 024 280 ₩
122 416 427 990 ₩
122 358 698 360 ₩
120 503 212 290 ₩
105 269 584 040 ₩
105 667 920 140 ₩
95 991 283 520 ₩
88 796 435 250 ₩
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
409 834 321 310 ₩
398 762 970 150 ₩
403 327 801 620 ₩
375 342 625 870 ₩
347 602 916 800 ₩
330 589 677 670 ₩
321 384 962 000 ₩
300 427 997 520 ₩
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
684 939 985 850 ₩
663 165 455 660 ₩
653 723 666 580 ₩
623 332 210 830 ₩
540 407 431 730 ₩
518 517 969 600 ₩
507 671 772 000 ₩
480 244 696 660 ₩
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
37 255 977 020 ₩
54 537 377 710 ₩
55 683 007 730 ₩
34 820 271 240 ₩
92 554 653 030 ₩
82 581 014 870 ₩
73 717 090 000 ₩
61 802 285 570 ₩
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
98 737 269 680 ₩
106 094 724 160 ₩
108 846 518 000 ₩
92 366 598 860 ₩
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
170 594 350 650 ₩
164 430 681 950 ₩
167 690 097 000 ₩
148 632 650 040 ₩
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
31.57 %
31.71 %
33.03 %
30.95 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
418 082 711 130 ₩
410 983 103 270 ₩
402 381 172 750 ₩
385 255 459 600 ₩
347 448 073 950 ₩
332 478 678 880 ₩
320 336 258 000 ₩
312 637 531 600 ₩
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
14 267 224 690 ₩
16 344 484 170 ₩
16 461 864 000 ₩
13 049 903 380 ₩
Last revenue report of DongKook Pharm was 31/03/2021. According to last financial report total revenue in DongKook Pharm was 143 895 330 560 South Korean won and changed by +30.22% since last year. Net income in DongKook Pharm was 15 125 283 260 ₩ in last quartal, net income changes to +21.13%.
Current cash DongKook Pharm - the sum of all of the cash a company has on the date of report. Current cash DongKook Pharm is 37 255 977 020 ₩
